Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Lodge

Showing results (111-120 of 135) with videos related to

Pageof 14
Sort By:
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Heteroatom-substitution as a strategy for increasing the potency of competitive NMDA antagonistsP L Ornstein, M B Arnold, W H Lunn, et al.
Neuropharmacology|December 16, 1998
Decahydroisoquinolines: novel competitive AMPA/kainate antagonists with neuroprotective effects in global cerebral ischaemiaM J O'Neill, A Bond, P L Ornstein, et al.
European Journal of Pharmacology|October 15, 1991
D,L-(tetrazol-5-yl) glycine: a novel and highly potent NMDA receptor agonistD D Schoepp, C L Smith, D Lodge, et al.
Journal of Medicinal Chemistry|December 8, 1995
(3SR,4aRS,6SR,8aRS)-6-(1H-tetrazol-5-yl)decahydroisoquinoline-3-carboxylic acid, a novel, competitive, systemically active NMDA and AMPA receptor antagonistP L Ornstein, M B Arnold, N K Allen, et al.
Neuropharmacology|December 16, 1998
Actions of kainate and AMPA selective glutamate receptor ligands on nociceptive processing in the spinal cordM J Procter, A K Houghton, E S Faber, et al.
Journal of Medicinal Chemistry|August 21, 1992
NMDA antagonist activity of (+/-)-(2SR,4RS)-4-(1H-tetrazol-5-ylmethyl)piperidine-2-carboxylic acid resides with the (-)-2R,4S-isomerP L Ornstein, D D Schoepp, M B Arnold, et al.
Neuropharmacology|June 16, 2000
LY377770, a novel iGlu5 kainate receptor antagonist with neuroprotective effects in global and focal cerebral ischaemiaM J O'Neill, L Bogaert, C A Hicks, et al.
Neuropharmacology|July 29, 1998
Sulphur-containing amino acids are agonists for group 1 metabotropic receptors expressed in clonal RGT cell linesA E Kingston, J Lowndes, N Evans, et al.
British Journal of Pharmacology|November 1, 1988
A comparison between the in vivo and in vitro activity of five potent and competitive NMDA antagonistsD Lodge, S N Davies, M G Jones, et al.
Neuropharmacology|September 1, 1995
In vitro and in vivo antagonism of AMPA receptor activation by (3S, 4aR, 6R, 8aR)-6-[2-(1(2)H-tetrazole-5-yl) ethyl] decahydroisoquinoline-3-carboxylic acidD D Schoepp, D Lodge, D Bleakman, et al.
Pageof 14

Showing results (111-120 of 135) with videos related to

Sort By:
Pageof 14
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Heteroatom-substitution as a strategy for increasing the potency of competitive NMDA antagonistsP L Ornstein, M B Arnold, W H Lunn, et al.
Neuropharmacology|December 16, 1998
Decahydroisoquinolines: novel competitive AMPA/kainate antagonists with neuroprotective effects in global cerebral ischaemiaM J O'Neill, A Bond, P L Ornstein, et al.
European Journal of Pharmacology|October 15, 1991
D,L-(tetrazol-5-yl) glycine: a novel and highly potent NMDA receptor agonistD D Schoepp, C L Smith, D Lodge, et al.
Journal of Medicinal Chemistry|December 8, 1995
(3SR,4aRS,6SR,8aRS)-6-(1H-tetrazol-5-yl)decahydroisoquinoline-3-carboxylic acid, a novel, competitive, systemically active NMDA and AMPA receptor antagonistP L Ornstein, M B Arnold, N K Allen, et al.
Neuropharmacology|December 16, 1998
Actions of kainate and AMPA selective glutamate receptor ligands on nociceptive processing in the spinal cordM J Procter, A K Houghton, E S Faber, et al.
Journal of Medicinal Chemistry|August 21, 1992
NMDA antagonist activity of (+/-)-(2SR,4RS)-4-(1H-tetrazol-5-ylmethyl)piperidine-2-carboxylic acid resides with the (-)-2R,4S-isomerP L Ornstein, D D Schoepp, M B Arnold, et al.
Neuropharmacology|June 16, 2000
LY377770, a novel iGlu5 kainate receptor antagonist with neuroprotective effects in global and focal cerebral ischaemiaM J O'Neill, L Bogaert, C A Hicks, et al.
Neuropharmacology|July 29, 1998
Sulphur-containing amino acids are agonists for group 1 metabotropic receptors expressed in clonal RGT cell linesA E Kingston, J Lowndes, N Evans, et al.
British Journal of Pharmacology|November 1, 1988
A comparison between the in vivo and in vitro activity of five potent and competitive NMDA antagonistsD Lodge, S N Davies, M G Jones, et al.
Neuropharmacology|September 1, 1995
In vitro and in vivo antagonism of AMPA receptor activation by (3S, 4aR, 6R, 8aR)-6-[2-(1(2)H-tetrazole-5-yl) ethyl] decahydroisoquinoline-3-carboxylic acidD D Schoepp, D Lodge, D Bleakman, et al.
Pageof 14